Pilot and team-science funding from Siteman Cancer Center to generate data for future NCI/NIH applications. Mechanisms include Clinical Trials, Pre-R01, Team Science, Genome Integrity Development Awards (GIDA), and Community Outreach & Engagement (COE) Supplements, with an emphasis on catchment-area priorities and health equity.
Eligibility Criteria:
-
Contact PI must be full-time faculty at Washington University, Saint Louis University, or University of Missouri–Columbia; SLU/MU faculty require a WU Siteman co-PI. Contact PI must be (or apply to be) a Siteman member by the stated deadlines. Minimum 5% effort for PI and any co-PI. Distinct science required if previously SIP-funded.
-
Clinical Trial category: Contact PI must be an active clinician; protocol to PRMC by full-application deadline; special emphasis on trials meeting catchment needs.
Funding Details:
-
Clinical Trials (new institutional trials): up to USD 300,000 total (directs) over ≤3 years; BTC Early Phase 1 trials: up to USD 75,000 total.
-
Pre-R01 (incl. Prevention/Control focus and MU–WU collaborative): up to USD 200,000 total over ≤2 years.
-
Team Science: up to USD 800,000 total over ≤2 years (interim competitive renewal: 1 year, up to USD 400,000).
-
GIDA: up to USD 100,000 total over 2 years (with collaboration from a CGI member; no effort/funds to the CGI co-investigator).
-
COE Supplements: up to USD 50,000 for 1 year (up to USD 100,000 with pre-approval) for community-engaged, disparities-focused aims.
Deadline:
-
Statement of Intent due: August 29, 2025 (4:00 p.m. CST).
-
Full application due: September 26, 2025 (4:00 p.m. CST).
-
Start date: January 1, 2026.
Where to Go for Further Information:
-
Submission: ProposalCentral (use SIP RDA forms; NIH PHS 398 where noted). SOI form is linked from the SIP RDA webpage.
-
Program contact: Steve Baer, Program Manager, [email protected]. Membership and mechanism-specific questions noted in the RFA (e.g., PRAB, PRMC, CGI).